Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts
出版年份 2015 全文链接
标题
Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts
作者
关键词
-
出版物
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 309, Issue 3, Pages H512-H522
出版商
American Physiological Society
发表日期
2015-06-09
DOI
10.1152/ajpheart.00137.2015
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1
- (2015) Sarah A. Swager et al. CARDIOVASCULAR PATHOLOGY
- MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures
- (2014) N. Muraoka et al. EMBO JOURNAL
- Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts
- (2014) Enrico Conte et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Antiproteinuric effect of pirfenidone in a rat model of anti-glomerular basement membrane glomerulonephritis
- (2014) Koji Takakura et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents
- (2013) Zhen Ma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pirfenidone Attenuates Cardiac Fibrosis in a Mouse Model of TAC-Induced Left Ventricular Remodeling by Suppressing NLRP3 Inflammasome Formation
- (2013) Yongliang Wang et al. CARDIOLOGY
- Hypoxia-Inducible Factor-1 Alpha in the Heart
- (2012) Satwat Hashmi et al. Cardiology in Review
- Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis
- (2012) Amiram Ariel et al. JOURNAL OF PATHOLOGY
- The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
- (2011) Takanori Yamazaki et al. HYPERTENSION RESEARCH
- PAI-1 in tissue fibrosis
- (2011) Asish K. Ghosh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Spotlight on microvascular permeability
- (2010) F.-R. E. Curry et al. CARDIOVASCULAR RESEARCH
- Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function
- (2010) Ranjeet M. Dongaonkar et al. CARDIOVASCULAR RESEARCH
- Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias
- (2010) Duy T. Nguyen et al. HEART RHYTHM
- Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice
- (2010) Kazutaka Ueda et al. JOURNAL OF CLINICAL INVESTIGATION
- Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
- (2008) Hisashi Oku et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Claudin-5 levels are reduced in human end-stage cardiomyopathy
- (2008) Tessily A. Mays et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search